Figure 3.
Figure 3. Long-term survival of DCVIPs in transplanted mice. Balb/c (H-2d) mice received transplants of BMS from B6 (H-2b) mice. CFSE-labeled DCVIPs were injected 2 days after transplantation. (A) The presence of CFSE-labeled DCVIPs in recipient spleens was determined at the indicated times by flow cytometry (n = 3). Inset: Histogram represents CFSE-labeling profile at day 5 after injection. (B) Ten days after injection, spleen CFSE-labeled DCVIPs were sorted, stimulated with LPS (1 μg/mL) for 24 hours, and analyzed for CD11c, CD40, CD45RB, and CD80 expression by flow cytometry. Sorted CFSE-labeled DCVIPs (104 cells) were incubated with allogeneic T cells (5 × 104) from B6 mice and proliferation was determined (n = 3). LPS-matured DCs (DCcontrols) were used as controls.

Long-term survival of DCVIPs in transplanted mice. Balb/c (H-2d) mice received transplants of BMS from B6 (H-2b) mice. CFSE-labeled DCVIPs were injected 2 days after transplantation. (A) The presence of CFSE-labeled DCVIPs in recipient spleens was determined at the indicated times by flow cytometry (n = 3). Inset: Histogram represents CFSE-labeling profile at day 5 after injection. (B) Ten days after injection, spleen CFSE-labeled DCVIPs were sorted, stimulated with LPS (1 μg/mL) for 24 hours, and analyzed for CD11c, CD40, CD45RB, and CD80 expression by flow cytometry. Sorted CFSE-labeled DCVIPs (104 cells) were incubated with allogeneic T cells (5 × 104) from B6 mice and proliferation was determined (n = 3). LPS-matured DCs (DCcontrols) were used as controls.

Close Modal

or Create an Account

Close Modal
Close Modal